Friday, March 21, 2025
spot_img

Borregaard ASA: Notice of Borregaard’s Annual General Meeting 2025

The Annual General Meeting of Borregaard ASA will be held on 10 April 2025 at 13:00 CEST as a digital meeting.

The following documents are attached:
– Notice of the Annual General Meeting
– Report on pay and other remuneration of senior management
– Recommendations of the nomination committee

Borregaard’s Annual Report 2024 is available at the company’s webpage: https://www.borregaard.com/investors/.

Notice of attendance is required for all shareholders. Deadline for registration of advance votes, proxies and instructions must be received no later than 08.04.2025 at 11:59pm (23:59 CEST). Also, shareholder must be logged in when the meeting starts.

The record date for this year’s Annual General Meeting is 03.04.2025 at 11:59pm (23:59 CEST). Only shares acquired at or before the record date are entitled to meeting and voting rights.

The notice will be sent to all shareholders today. Notice of the Annual General Meeting and other documents relating to items of business, as well as further information concerning the rights of shareholders, may be found at https://www.borregaard.com/investors/.

The Annual General Meeting will be simultaneously interpreted to English.

Login will open at 12:00 CEST at the date of the Annual General Meeting.

Borregaard ASA
Sarpsborg, 20 March 2025

Contact:
Lotte Kvinlaug, Investor Relations Officer, +47 922 86 909

This information is subject to the disclosure requirements pursuant to Section 5 -12 of the Norwegian Securities Trading Act.

Attachments

  • Notice of the Annual General Meeting
  • Report on pay and other remuneration of senior management
  • Recommendations of the nomination committee

Powered by SlickText.com

Hot this week

FDA Approves New Prostate Cancer Imaging Agent Gozellix®

MELBOURNE, Australia and INDIANAPOLIS, March 21, 2025 ...

Ordinær generalforsamling 2025

Indkaldelse til ordinær generalforsamling den 23. april 2025 er...

Net Asset Value(s)

FORESIGHT VENTURES VCT PLC LEI: 213800R88MRC4Y3OIW86 NAV ANNOUNCEMENT21 MARCH...

Topics

FDA Approves New Prostate Cancer Imaging Agent Gozellix®

MELBOURNE, Australia and INDIANAPOLIS, March 21, 2025 ...

Ordinær generalforsamling 2025

Indkaldelse til ordinær generalforsamling den 23. april 2025 er...

Net Asset Value(s)

FORESIGHT VENTURES VCT PLC LEI: 213800R88MRC4Y3OIW86 NAV ANNOUNCEMENT21 MARCH...

Net Asset Value(s)

                 WisdomTree Issuer plc – Daily Fund Prices 20-March-25        WisdomTree...

Chimerix Reports Fourth Quarter and Year End 2024 Financial Results

New Drug Application (NDA) for Dordaviprone as Treatment for...
spot_img

Related Articles

Popular Categories

spot_img